Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Case report
Remarkable Response to the Triplet Combination of Olaparib with Pembrolizumab and Bevacizumab in the Third-Line Treatment of an Ovarian Clear Cell Carcinoma Patient with an ARID1A Mutation: A Case Report
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,932 | Dovepress* | 7,056+ | 373 | 7,429 | |
| PubMed Central* | 876 | 175 | 1,051 | ||
| Totals | 7,932 | 548 | 8,480 | ||
| *Since 2 April 2022 | |||||
View citations on PubMed Central and Google Scholar